Gene transfer of Fas ligand induces tumor regression in vivo. - Wikidata - awgldk - TriplyDB

Gene transfer of Fas ligand induces tumor regression in vivo.

Gene transfer of Fas ligand induces tumor regression in vivo.

http://www.wikidata.org/entity/Q33731661

about

LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death Natural selection of tumor variants in the generation of "tumor escape" phenotypes Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer Fas ligand expression in human and mouse cancer cell lines; a caveat on over-reliance on mRNA data.Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy An overview of caspase: Apoptotic protein for silicosis Endothelial cell-derived CD95 ligand serves as a chemokine in induction of neutrophil slow rolling and adhesion CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden.Fas and Fas ligand in gut and liver.Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice.Apoptosis in oncology.Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells Fas receptor-mediated apoptosis: a clinical application?Alterations in molecular killing mechanisms: implications in skin disease.Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.Mechanisms of malignant glioma immune resistance and sources of immunosuppression Testicular FasL is expressed by sperm cells.All in the head: obstacles for immune rejection of brain tumours.Enhancing the bystander killing effect of an oncolytic HSV by arming it with a secretable apoptosis activator.Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer Targeted molecular imaging.Death receptors in chemotherapy and cancer.In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape.Considering Fas ligand as a target for therapy.Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment.Targeting the Fas/Fas ligand pathway in cancer.Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival.Fas ligand triggers pulmonary silicosis Human melanoma cells do not express Fas (Apo-1/CD95) ligand Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer T cell-tumor cell: a fatal interaction?Anti-liver cancer activity of TNF-related apoptosis-inducing ligand gene and its bystander effects.Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.Review article: immune suppression and colorectal cancer.

P2860

Q22010722-B97ED5C9-D33A-4551-9739-B88843DDEFE2 Q24551158-D85AD75C-4C88-41A2-948D-074AE04C42EC Q24801183-2FF5687B-EF63-40D1-96E7-1C8159D0D060 Q25256768-56C3A10C-7434-475B-812C-1C52223B3A97 Q28069360-21B528C1-A853-4A1E-B9ED-FD7C97CC15C5 Q28384832-22D3CD30-A527-47E9-8C9D-D1E69BA0D08D Q28821976-F3270E5D-6820-41FA-AE69-A9EE7DB31BCA Q33195823-1E1D9CF0-7475-4F99-A36C-787E3C5E6415 Q33530092-B3F52C94-3E5B-46D1-8FAC-BF832D95E8CC Q33860215-34DB0856-9731-417F-83C7-C1F8D6C53469 Q33997713-2041DCBD-A4F4-4CC4-B16F-0948F85EA515 Q34091455-65E5FC71-1E1B-4B18-86A9-F026ABC4CF1A Q34220661-33E40E35-3B99-45C4-B38E-4152746C0204 Q34280097-0AA18955-0AB7-4AA5-B2B4-108066B291C5 Q34495634-35380CE0-D134-4C70-ADD7-F0D3CF0C7A81 Q34567275-FA6936AD-2E3D-4469-94D6-09DFE720F174 Q34592338-36B7B093-A525-4DEA-B5A7-B598479C7F59 Q34661793-66637B51-97A6-4C1D-9F4E-34EB52F52589 Q34725906-A9CE599F-5ADB-43F6-B43B-AB96AF2A6BA5 Q34842204-8FD173D4-FE35-4D76-AF60-2D39AFFA4A26 Q35154965-8C12B1B7-52C4-4440-AF3D-8A82238E9CB0 Q35209364-3073C260-F5E3-497B-A62E-336942017743 Q35223578-1F2EB045-9840-486A-8A6A-A578417567DE Q35354010-2F22FDB1-7B56-4DD7-8F18-ACE618EC4C8E Q35630559-2B1895A1-639A-43FD-993F-89A892968AAF Q35743149-F1616A8B-4F22-423B-86E0-3B846EA636CA Q35847696-01B910DE-53C1-424F-8FFB-40A35BECA6B0 Q35956638-4FCAA8CC-DCD6-48C4-BF35-836EAD4A9AC5 Q36066300-6264B153-899C-440A-B08E-ACD4F6EE6244 Q36200046-FE823FD3-A525-404E-BC4A-EC1351B06DB1 Q36268329-952117A1-3222-4601-A678-55C5B45770A7 Q36368504-816DD486-06E1-4353-9326-A4C53056CE6C Q36369388-50F7CF0F-DB85-4230-B171-1C152ABF0F59 Q36454464-E36AE57B-6C1F-4A6D-8458-A30F82FC755B Q36460454-CBECBF02-F873-4268-938F-1B765E223290 Q36473831-35039997-7E76-4084-A0D7-654B8641AFDC Q36474111-0AF0AB09-C28C-404B-95A4-B8269E4FFCDC Q36476449-275AFEF1-D27A-422E-BFF1-3BC8441981D3 Q36501180-53C72D90-7BB2-4CF1-B23D-EAB0E942D7DA Q36609898-496AFC48-8189-4543-9518-733469DB6161

P2860

Gene transfer of Fas ligand induces tumor regression in vivo.

http://www.wikidata.org/entity/Q33731661

description

1997 nî lūn-bûn

@nan

1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Gene transfer of Fas ligand induces tumor regression in vivo.

@ast

Gene transfer of Fas ligand induces tumor regression in vivo.

@en

type

label

Gene transfer of Fas ligand induces tumor regression in vivo.

@ast

Gene transfer of Fas ligand induces tumor regression in vivo.

@en

prefLabel

Gene transfer of Fas ligand induces tumor regression in vivo.

@ast

Gene transfer of Fas ligand induces tumor regression in vivo.

@en

P1433

Q33731661-99379885-9B16-4F92-A63B-F699DEBFE931

P1476

Q33731661-8F2AE95E-124B-4960-84CB-D404D6BB1772

P2093

Q33731661-3A3C011B-69D4-48C5-919D-78E8B8A99FDA

Q33731661-463B8AD7-BB82-47E7-910C-40EEAE269B66

Q33731661-B277570E-EA8C-4F90-BD58-32D0DE42B5FA

Q33731661-CBA95200-984D-4389-957D-341C2A571031

P2860

Q33731661-09ADA324-5579-4BD0-BCED-CFF0F36D8F31

Q33731661-239A37A3-DF4A-4AE9-AB08-A915377F5C5C

Q33731661-367E865E-1167-4C21-BFEA-86E6D14BB1B2

Q33731661-47352015-5FD6-44DE-95A2-6682EC239559

Q33731661-483C24ED-5602-4035-9907-B628542A07CD

Q33731661-490CFEEB-8683-4CE1-96AD-200C1ED69A88

Q33731661-4CBC210F-5699-4348-A358-6557647B768C

Q33731661-6A7E4C52-3D88-4BF4-BB99-512622B21DB4

Q33731661-6DA29A5B-2016-4E4F-9BC8-8EE46E4913AE

Q33731661-8189BA01-1B38-4572-AAFB-C9F96E8BC8E5

P304

Q33731661-F74E6967-6B47-43F1-9DA4-EA0BF2847745

P31

Q33731661-C61AEA78-0A78-4E38-AF9E-86DD6DCBC935

P356

Q33731661-959B7225-CB25-486D-975D-3ADFBAF77C37

P407

Q33731661-E341F101-A0D1-4535-9B27-ECD80530012B

P433

Q33731661-743D38F7-A192-41C9-8245-B4FE016353CD

P478

Q33731661-FDF8686C-6206-42FC-8953-E0339245917E

P577

Q33731661-299E7A45-E5F1-4278-9AAB-BD3CE2E27AEF

P5875

Q33731661-EB38B1EE-EC50-475B-AC35-4C11EC2C0F5F

P698

Q33731661-329FBDEF-6835-4CDE-AB51-71E54538A663

P932

Q33731661-ECDEC4BC-57FA-41B8-81FF-7B4F792CE9C6

P356

PNAS.94.25.13862

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Gene transfer of Fas ligand induces tumor regression in vivo.

@en

P2093

D Gordon

http://www.w3.org/2001/XMLSchema#string

E G Nabel

http://www.w3.org/2001/XMLSchema#string

G J Nabel

http://www.w3.org/2001/XMLSchema#string

H Arai

http://www.w3.org/2001/XMLSchema#string

P2860

A severe combined immunodeficiency mutation in the mouse

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

The Fas death factor

Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

Lethal effect of the anti-Fas antibody in mice.

The nude mouse in cancer research.

The beige mutation in the mouse selectively impairs natural killer cell function.

P304

13862-13867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.94.25.13862

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1997-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13839194

http://www.w3.org/2001/XMLSchema#string

P698

9391118

http://www.w3.org/2001/XMLSchema#string

P932

28398

http://www.w3.org/2001/XMLSchema#string